Nano One Materials Corp. (“Nano One or the Company”) is pleased to announce the issuance of Taiwanese Patent No. 201207152 related to batteries utilizing the proprietary lithium mixed metal oxides developed by Nano One. The method for making the proprietary oxides is discussed in previously issued U.S. Patent Nos. 9,136,534 and 9,159,999.
Patent agent and Director, Dr Joseph Guy states that “Nano One has now been issued three patents in relatively short order with only minor revisions indicating an exclusive technological position and this battery patent gives the Company intellectual property protection in a commercially significant application of its proprietary technology. The Company has additional patent applications pending in the US and foreign jurisdictions and this patent is evidence of an expanding intellectual property portfolio.”
“This battery patent is significant in a few ways,” explains CEO Dan Blondal “and marks another milestone in the growth and valuation of Nano One’s patent portfolio. The Taiwanese are global battery players and this issuance provides validation and positioning in the Asian market. This third patent also extends Nano One’s patent portfolio across the value chain to include processing, materials and now batteries.”
NANO ONE MATERIALS CORP.
Dan Blondal, CEO
For information with respect to Nano One or the contents of this news release, please contact John Lando (President) at (604) 669-2701 FREE or visit the website at www.nanoone.ca.
About Dr. Joseph Guy
Dr. Joseph Guy is Nano One’s patent agent and serves on Nano One’s board of directors. He is a Patent Agent with Perkins Law Firm’s Intellectual Property group focusing on complex technologies including material science, electronic components, pharmaceuticals and medical products. He has more than 23 years of experience prosecuting patents and serving as expert witness on intellectual property matters. Dr. Guy was awarded a Ph.D. in Chemistry from the University of Wisconsin-Milwaukee in physical inorganic chemistry with a focus on organometallic complexes. After a post-doctoral fellowship at Naval Research Laboratories, Dr. Guy joined E.I. duPont de Nemours & Co. in Brevard, North Carolina where he conducted research in medical imaging technologies.
Dr. Guy later transitioned to intellectual property manager where his primary responsibility was management of the Intellectual Property portfolio and license negotiations for the Medical Products Division. The Medical Products Division was divested to Sterling Diagnostic Imaging, Inc. in 1996 and Dr. Guy was appointed corporate patent manager responsible for managing the intellectual property for a multinational corporation. Dr. Guy has authored numerous references in peer-reviewed journals and has written and prosecuted over 1000 U.S. and foreign patent applications, with more than 400 issued U.S. Patents and numerous foreign patents. His corporate research, management experience and intellectual property backgrounds merge to provide excellent experience in the development of an IP portfolio tailored to augment corporate strategies.